Risk of progression of monoclonal gammopathy of undetermined significance into lymphoplasmacytic malignancies: determining demographic differences in the USA

• Ronald S. Go,
• Herbert C. Heien,
• Lindsey R. Sangaralingham,
• Elizabeth B. Habermann,
• Nilay D. Shah

Affiliations

Ronald S. Go

Division of Hematology Mayo Clinic, Rochester, MN, USA;Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; Mayo Clinic, Rochester, MN, USA

Herbert C. Heien

Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; Mayo Clinic, Rochester, MN, USA

Lindsey R. Sangaralingham

Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; Mayo Clinic, Rochester, MN, USA

Elizabeth B. Habermann

Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; Mayo Clinic, Rochester, MN, USA

Nilay D. Shah

Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; Mayo Clinic, Rochester, MN, USA